...Fucheng Zhang; Qin Tian; Yaojun Wang Background: The aim of this study was to investigate the role of far upstream element-binding protein 1 (FUBP1) in gastric cancer development. Patients and Methods : Using immunohistochemistry, we detected FUBP1 expression in 18 chronic superficial gastritis...

...-499 with the risk of gastric cancer (GC) in the Chinese population. Patients and Methods: The rs3746444 (A>G) SNPs were genotyped in 201 GC and 213 non-cancer subjects in a case-control study by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Results...

...Mi-Sun Ahn; Seok-Yun Kang; Hyun-Woo Lee; Seong-Hyun Jeong; Joon-Seong Park; Kwang-Jae Lee; Yong-Kwan Cho; Sang-Uk Han; Soon-Young Lee; Ho-Yeong Lim; Jin-Hyuk Choi Background: Despite the small but significant survival benefit of adjuvant chemotherapy in locally advanced gastric cancer (LAGC...

.... Gastric cancer Esophageal cancer Systemic therapy Overall survival Second-line therapy Review Article · Übersichtsarbeit Onkologie 2012;35:204 209 DOI: 10.1159/000337415 Published online: March 15, 2012 Advanced Gastroesophageal Carcinoma: An Update on the Current Therapeutic Landscape Yuki...

... for gastric cancer chemotherapy remains unclear. Patients and Methods: Among 484 patients with metastatic gastric cancer, who had received chemotherapy in 4 Japanese hospitals, we identified 28 patients who had received either paclitaxel- or docetaxel-containing chemotherapy and who were refractory...

...François-Régis Ferrand; Eric Gontier; Sophie Guymar; Thierry Fagot; Bernard Ceccaldi; Jean-Valère Malfuson; Thierry de Revel We report the case of a 62-year-old woman with a metastatic gastric cancer complicated by diffuse bone marrow carcinomatosis, disseminated intravascular coagulation (DIC...

...Holger G. Hass; Ute Smith; Christina Jäger; Michael Schäffer; Ulrich Wellhäußer; Thomas Hehr; Hans-Ulrich Markmann; Oliver Nehls; Claudio Denzlinger Aim: The aim of this study was to evaluate survival rates and treatment response in stage I–IV gastric cancer in relation to tumor stage (TNM...

...Jae Hyun Choi; Hye-Suk Han; Ho-chang Lee; Ok-Jun Lee; Jeong Tae Kim; Sung-Nam Lim; Ki Hyeong Lee; Seung Taik Kim Background: Trastuzumab, a humanized monoclonal antibody directed against human epidermal growth factor receptor 2 (HER2), has been shown to be active against metastatic gastric cancers...

...Florian Weissinger; Marc Reymond; Klaus Dumke; Martin Krüger Background: For patients with HER2overexpressing gastric cancer, there is an improved prognosis with additional trastuzumab to chemotherapy with a platinum compound and a fluoropyrimidin in firstline therapy. Secondline combinations...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Trastuzumab EGFR HER-2 Gastric cancer Case Report · Kasuistik Onkologie 2011;34:42 45 DOI: 10.1159/000323345 Published online: January 17, 2011 Trastuzumab plus...

... factor in gastric cancer, no consensus was reached on its clinical importance. In this study, we aimed to determine the effect of tumor size on survival in patients with pT3 gastric cancer. Patients and Methods: A total of 232 patients with pT3 gastric cancer, who underwent curative gastrectomy with D2...

...Yves Dittmar; Nicole Posorski; Falk Rauchfuss; Rigo Voigt; Michael Heise; Karin Jandt; Mieczyslav Gajda; Utz Settmacher Background: Gastric cancer is one of the most frequent malignancies worldwide. More than 50% of all patients present with advanced stage of disease, with long-time survival...

... resected gastric cancer, but the superiority of n ratio to pN stage could not be proved. 16 2 2010 © 2010 S. Karger AG, Basel 2010 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized...

...N.A. Willich Intraoperative radiation therapy (IORT) is able to contribute to local tumor control in the context of surgical resections by means of delivery of high single doses of ionizing radiation. In the treatment of gastric cancer IORT is applied either as sole irradiation modality with doses...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Gastric cancer E-cadherin Catenin...

...H. Wilke; P. Preusser; M. Stahl; H.J. Meyer; U. Fink; W. Achterrath; P. Busche; J. Meyer; A. Harstrick; H.-J. Schmoll; S. Seeber Background : Cisplatin is an active drug in advanced gastric cancer and acts synergis-tically with etoposide and 5-fluorouracil (5-FU). These were the reasons for adding...

... (Epi) could increase the efficacy of the combination. This was examined in patients with advanced gastric cancer who had previously received chemotherapy with FAM (5-FU + adriamycin + mitomycin) and relapsed. Patients and Method : The schedule was conducted in 30 patients who had previously received...

...K. Buhl; P. Schlag; M.M. Linder; G. Geiger; C. Herfarth; M. Trede Background: The lack of proven effects of postoperative adjuvant chemotherapy in gastric cancer stimulates new therapeutic approaches. In vitro studies applying different kinds of interferon to renal cell carcinomas, however...

...J.J. Bonenkamp; A.M.G. Bunt; C.J.H. van de Velde Despite declining incidence and improved surgical care, gastric cancer remains associated with high mortality. Incidence and survival show remarkable geographic differences. Japanese patients have a much better chance of cure than Western patients...

...F. Bozzetti; G. Bonfanti; L. Gennari Background: There is still a matter of controversy whether a subtotal gastrectomy has the same therapeutic potential as a total gastrectomy in distal gastric cancer. Whether all or a subgroup of patients can benefit from total gastrectomy can be answered only...